Instruction for use: Iodomarin 200

ATX Code H03CA Potassium Jodid

Active substance Potassium Jodid

Pharmacological group

Inorganic iodine preparation [Thyroid and parathyroid hormones, their analogs and antagonists (including antithyroid agents) / 67 /]

Nosological classification (ICD-10)

E01 Thyroid gland diseases associated with iodine deficiency and similar conditions

Hormonal deficiency of the thyroid gland due to iodine deficiency in the body, Goiter endemic, Iodine deficiency alimentary state, Iodine deficiency disease, Iodine Deficiency, Endemic cretinism

E04.0 Non-toxic diffuse goiter

Diffuse nontoxic goiter, Diffuse euthyroid goiter

Composition and form of release

Iodomarin®100

Tablets 1 table.

Potassium iodide 131 μg

(Corresponding to 100 μg of iodine)

Auxiliary substances: lactose monohydrate; Magnesium carbonate basic light; gelatin; Carboxymethyl starch sodium salt; Silicon dioxide, high-dispersed; Magnesium stearate

In glass bottles of 50 or 100 pieces; In a carton box 1 bottle.

Iodomarin®200

Tablets 1 table.

Potassium iodide 262 μg

(Corresponding to 200 μg of iodine)

Auxiliary substances: lactose monohydrate; Magnesium carbonate basic light; gelatin; Carboxymethyl starch sodium salt; Silicon dioxide, high-dispersed; Magnesium stearate

In the contour acheikova packing 25 pcs .; In a carton box of 2 or 4 packs.

Description of dosage form

Flat on both sides of the tablet white or almost white, with a one-sided notching for division.

Characteristic

Inorganic iodine preparation.

pharmachologic effect

Pharmacological action - filling iodine deficiency.

It prevents the development of iodine deficiency states, normalizes the function of the thyroid gland, which is disturbed by iodine deficiency.

Pharmacodynamics

Iodine promotes normal activity of the thyroid gland, the hormones of which provide the correct metabolism in the body, regulate the activity of the brain, nervous and cardiovascular systems, sex and breast, the growth and development of the child.

Indications

Prevention of iodine deficiency disorders in areas with iodine deficiency, primarily in children, adolescents, pregnant and lactating women, treatment of diffuse non-toxic and euthyroid goiter in children (including newborns and adolescents) and adults.

Contraindications

Hypersensitivity to iodine, hyperthyroidism, toxic adenoma of the thyroid gland, nodular goiter with doses of 300-1000 mcg / day (with the exception of pre-operative iodine therapy), dermatitis herpetiform (senile) dermatitis.

pregnancy and lactation

At pregnancy and thoracal feeding application in doses of 200 mkg / day is recommended.

Side effects

At preventive use at any age, as well as in the therapeutic use in neonates, children and adolescents, side effects are usually not observed. In rare cases, a constant intake of the drug may lead to the development of "iodism," which can be manifested by a metallic taste in the mouth, swelling and inflammation of the mucous membranes (rhinitis, conjunctivitis, bronchitis), iodine fever, and iodine acne. Very rarely - Quincke's edema, exfoliative dermatitis. When using the drug at a dose of more than 150 mcg / day, latent hyperthyroidism can go into a manifest form. When doses from 300 to 1000 mcg / day are used, hyperthyroidism may develop (especially in elderly patients with goitre for a long period, with nodular or diffuse toxic goiter).

Interaction

It is possible to strengthen or weaken the effect and the development of side effects when combined with lithium salts, potassium-sparing diuretics and substances that inhibit the formation of thyroid hormones.

Dosing and Administration

Inside, after eating, squeezed with enough liquid. For the prevention of goiter: Adults and adolescent children - 100-200 mg / day; Newborns and children - 50-100 mcg / day; At pregnancy and thoracal feeding - 200 mkg / sut.

Prevention of recurrence of goiter after surgery for goitre or after the completion of drug treatment of goiter with thyroid hormone drugs: 100-200 mcg / day.

Preventive drug intake should be carried out for several years, often - all life.

Treatment of goiter: adults up to 45 years - 300-500 mcg / day; Newborns, children and adolescents - 100-200 mcg / day; Course of treatment in newborns - 2-4 weeks; In children, adolescents and adults - 6-12 months or more (according to the decision of the attending physician).

storage Conditions

At a temperature not exceeding 25 ° C.

Keep out of the reach of children.

shelf life

3 years.

Do not use after the expiry date printed on the package.